Application Information

This drug has been submitted to the FDA under the reference 021964/001.

Names and composition

"RELISTOR" is the commercial name of a drug composed of METHYLNALTREXONE BROMIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021964/001 RELISTOR METHYLNALTREXONE BROMIDE SOLUTION/SUBCUTANEOUS 12MG per 0.6ML (12MG per 0.6ML)
021964/002 RELISTOR METHYLNALTREXONE BROMIDE SOLUTION/SUBCUTANEOUS 8MG per 0.4ML (8MG per 0.4ML)
021964/003 RELISTOR METHYLNALTREXONE BROMIDE SOLUTION/SUBCUTANEOUS 12MG per 0.6ML (12MG per 0.6ML)
208271/001 RELISTOR METHYLNALTREXONE BROMIDE TABLET/ORAL 150MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021964/001 RELISTOR METHYLNALTREXONE BROMIDE SOLUTION/SUBCUTANEOUS 12MG per 0.6ML (12MG per 0.6ML)
021964/002 RELISTOR METHYLNALTREXONE BROMIDE SOLUTION/SUBCUTANEOUS 8MG per 0.4ML (8MG per 0.4ML)
021964/003 RELISTOR METHYLNALTREXONE BROMIDE SOLUTION/SUBCUTANEOUS 12MG per 0.6ML (12MG per 0.6ML)
208271/001 RELISTOR METHYLNALTREXONE BROMIDE TABLET/ORAL 150MG
208592/001 METHYLNALTREXONE BROMIDE METHYLNALTREXONE BROMIDE INJECTABLE/SUBCUTANEOUS 12MG per 0.6ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved